Jayson Bedford
Stock Analyst at Raymond James
(3.85)
# 694
Out of 5,131 analysts
324
Total ratings
55.37%
Success rate
7.77%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Outperform | $20 → $27 | $31.55 | -14.42% | 2 | Oct 30, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $572.75 | +5.28% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $23.43 | -18.91% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $124.64 | +17.14% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $209.72 | -0.34% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $91.45 | +23.56% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $151.27 | +18.99% | 22 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $83.25 | +22.52% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $70.98 | +43.70% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $95.72 | +29.54% | 26 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $328 → $360 | $278.55 | +29.24% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $204 → $185 | $132.27 | +39.87% | 7 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $202.74 | +33.18% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $10.18 | -1.77% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $108.56 | +149.63% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $24.19 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.35 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $83.01 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $20.15 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $96.95 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $7.11 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $74.85 | +14.90% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.56 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $13.15 | - | 3 | Jan 2, 2018 |
Axogen
Oct 30, 2025
Maintains: Outperform
Price Target: $20 → $27
Current: $31.55
Upside: -14.42%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $572.75
Upside: +5.28%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $23.43
Upside: -18.91%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $124.64
Upside: +17.14%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $209.72
Upside: -0.34%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $91.45
Upside: +23.56%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $151.27
Upside: +18.99%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $83.25
Upside: +22.52%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $70.98
Upside: +43.70%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $95.72
Upside: +29.54%
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $278.55
Upside: +29.24%
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $132.27
Upside: +39.87%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $202.74
Upside: +33.18%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $10.18
Upside: -1.77%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $108.56
Upside: +149.63%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $24.19
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.35
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $83.01
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $20.15
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $96.95
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $7.11
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $74.85
Upside: +14.90%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $2.56
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $13.15
Upside: -